AIM ImmunoTech Inc. (AIM): debt financing — AIM ImmunoTech raises $2.5M via unsecured promissory note with Streeterville Capital

On November 18, 2025, AIM ImmunoTech Inc. (the “Company”, “we”, “us” or “our”) entered into a Note Purchase Agreement (the “ Note Purchase Agreement ”) with Streeterville Capital, LLC (the “ Investor ”) and consummated the sale to such Investor of an unsecured Promissory Note (the “ Note ”) with an original principal amount of $3,301,250 in a private placement (the “ Private Placement ”) that closed on November 18, 2025. The Note carries an original issuance discount of $781,250 and the Company agreed to pay $20,000 to the Investor to cover the Investor’s legal and administrative transaction costs, each of which were included in the original principal amount and deducted from the proceeds of the Note received by the Company which resulted in a purchase price received by the Company of $2,500,000. The Note bears interest at ten percent (10%) per annum compounded daily. The maturity date of the Note is 24 months from the date of its issuance (the “ Maturity Date ”).